Search

Search Constraints

You searched for: Author/Creator Hong, Brian V.

Search Results

1. Altered HDL Cholesterol Efflux Capacity and LCAT Activity is APOE‐Specific in Alzheimer Disease and Mild Cognitive Impairment Patients. (20th December 2022)

2. Alzheimer's Disease Patients, Especially ApoE4 Carriers, Have Significantly Reduced High‐density Lipoprotein Particle Size Revealed by Negative‐stained Transmission Electron Microscopy. (20th December 2022)

3. HDL particle morphology in Alzheimer's disease patients compared to healthy human subjects and chemically modified HDL. (31st December 2021)

4. Reduced cholesterol efflux capacity of HDL particles from Alzheimer's disease patients is not related to differences in lipoprotein profiles. (1st February 2022)

5. Reduced cholesterol efflux capacity of HDL particles from Alzheimer's disease patients is not related to differences in lipoprotein profiles. (December 2021)